Testing effectiveness (Phase 2)Study completedNCT05421429What this trial is testingKN057 Multiple Dose Study in Moderately Severe to Severe HemophiliaWho this might be right forHemophilia Suzhou Alphamab Co., Ltd. 24
Very early researchUnknownNCT06119659What this trial is testingSafety and Efficacy Clinical Study of Severe Hemophilia B Treatment With KL001Who this might be right forHemophilia B Without Inhibitor Zhejiang University 9
Testing effectiveness (Phase 2)Ended earlyNCT03597022What this trial is testingMultiple Escalating Dose Study of BAY1093884 in Adults With Hemophilia A or B With or Without InhibitorsWho this might be right forHemophilia A and B Bayer 24
Large-scale testing (Phase 3)Looking for participantsNCT05145127What this trial is testingOpen-Label Extension Study of Marstacimab in Hemophilia Participants With or Without InhibitorsWho this might be right forHemophilia AHemophilia B Pfizer 245
Not applicableStudy completedNCT03818529What this trial is testingATHN 8: Previously Untreated Patients (PUPs) Matter StudyWho this might be right forHemophiliaHemophilia AHemophilia B+5 more American Thrombosis and Hemostasis Network 237
Early research (Phase 1)Study completedNCT04072237What this trial is testingStudy of Coagulation Faction VIIa Variant Marzeptacog Alfa (Activated) in Adult Subjects With HemophiliaWho this might be right forHemophilia AHemophilia BHemophilia A With Inhibitor+3 more Catalyst Biosciences 11